In line with this concept, no homozygous loss-of-function mutation of CHK1 has been detected in a wide range of human tumours (Remmerie and Janssens 2019), an observation suggesting that cells with defective CHK1 are eliminated during tumorigenesis. The gene discussed is CHEK1; the disease is neoplasm.